Question 1

What does Puma Biotechnology do in rare disease treatment?

Accepted Answer

Puma Biotechnology is a biopharmaceutical company with a focus on development and commercialization of innovative products for cancer care. The company develops therapies for HER2-positive breast cancer and other oncology indications, with advanced clinical trials ongoing.

Question 2

Does Puma Biotechnology have a rare disease division?

Accepted Answer

Puma Biotechnology is a diversified pharmaceutical company headquartered in Los Angeles, United States, founded in 2010. While it operates across multiple therapeutic areas, it maintains a significant rare disease portfolio with 0 active rare disease programs. Many of its rare disease treatments hold orphan drug designations from the FDA.

Question 3

How can I find Puma Biotechnology clinical trials for rare diseases?

Accepted Answer

The clinical trials section on this page shows active and recruiting rare disease trials sponsored by Puma Biotechnology, pulled live from ClinicalTrials.gov. Each trial card includes the study phase, recruitment status, conditions being studied, number of trial sites, and a direct link to the full study record. You can also explore individual disease pages to see trials from all sponsors for a specific condition.

Question 4

How do I enroll in a Puma Biotechnology clinical trial?

Accepted Answer

To explore enrollment, find a recruiting trial in the clinical trials list on this page and click "View full study" to see the full ClinicalTrials.gov record, which includes eligibility criteria, study locations, and contact information for each trial site. Your doctor can also help determine if a specific trial is appropriate for your condition. Not all trials are open at every location, so check the site list for one near you.

Question 5

What FDA-approved rare disease drugs does Puma Biotechnology have?

Accepted Answer

None that we track as of October 2026. No Puma Biotechnology label in the FDA's openFDA database matches a rare disease on Trial Friend, which usually means the company has no approved product yet or its approved drugs are for common conditions. In development: the trials list on this page shows what Puma Biotechnology is recruiting for now, and the FDA calendar lists any application once a decision date is public.

Question 6

When was Puma Biotechnology founded and where is it based?

Accepted Answer

Puma Biotechnology was founded in 2010 and is headquartered in Los Angeles, United States. The company has been active for 16 years. It trades publicly under the ticker symbol PBYI.

Puma Biotechnology

Focus areas at Puma Biotechnology

Active Clinical Trials

FDA-Approved Drugs

Frequently Asked Questions About Puma Biotechnology